Accurate Investment Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-48,355
Closed -$3.68M 5
2020
Q1
$3.68M Sell
48,355
-2,074
-4% -$177K 2.99% 8
2019
Q4
$4.46M Buy
50,429
+2,595
+5% +$215K 2.91% 14
2019
Q3
$3.62M Sell
47,834
-300
-0.6% -$20.6K 2.65% 22
2019
Q2
$3.5M Buy
48,134
+1,817
+4% +$143K 2.66% 23
2019
Q1
$3.73M Buy
46,317
+488
+1% +$39.9K 2.93% 19
2018
Q4
$4.22M Buy
45,829
+112
+0.2% +$9.85K 3.82% 6
2018
Q3
$4.32M Buy
45,717
+216
+0.5% +$20.5K 2.99% 11
2018
Q2
$4.22M Buy
45,501
+938
+2% +$91.6K 3.1% 6
2018
Q1
$4.22M Sell
44,563
-435
-1% -$47.8K 3.19% 5
2017
Q4
$4.35M Sell
44,998
-9,133
-17% -$861K 3.2% 6
2017
Q3
$4.81M Sell
54,131
-253
-0.5% -$19.3K 3.63% 1
2017
Q2
$3.94M Sell
54,384
-378
-0.7% -$25.4K 3.24% 3
2017
Q1
$3.57M Buy
54,762
+4,058
+8% +$255K 2.88% 15
2016
Q4
$3.17M Buy
50,704
+3,437
+7% +$210K 2.83% 16
2016
Q3
$2.98M Buy
47,267
+709
+2% +$45.9K 2.72% 17
2016
Q2
$2.88M Buy
46,558
+2,645
+6% +$161K 3.09% 14
2016
Q1
$2.51M Buy
43,913
+8,198
+23% +$457K 2.39% 20
2015
Q4
$2.12M Buy
+35,715
New +$2.06M 1.93% 21

Other funds holding ABBV

Accurate Investment Solutions's ABBV Position: Q2 2020 in Review

Accurate Investment Solutions sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 48,355 shares — an estimated $3.68M sold.

Accurate Investment Solutions first reported a position in ABBV in Q4 2015 and held it in 18 quarters. The position peaked at $4.81M in Q3 2017. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

  • Accurate Investment Solutions reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
  • Accurate Investment Solutions sold 48,355 AbbVie shares in Q2 2020, an estimated $3.68M.
  • Accurate Investment Solutions first reported a position in AbbVie in Q4 2015 and held it in 18 quarters.
  • Accurate Investment Solutions's AbbVie position peaked at $4.81M in Q3 2017.
  • 2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Accurate Investment Solutions's 13F filing for Q2 2020.